Approved Blood Cancer Inhibitors May Be Effective Therapy for Ovarian Tumors, Study Finds

Approved Blood Cancer Inhibitors May Be Effective Therapy for Ovarian Tumors, Study Finds
A class of inhibitors approved for the treatment of several blood cancers may be an effective therapy for ovarian cancer patients who have mutations in the ARID1A gene, according to researchers. The study, “Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer,” was published in the journal Cell Reports. Cancer cells are known to contain significant epigenetic alterations,

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *